Company: NCEL
Filing Date: 2025-06-30
Form Type: 6-K
Source: 0001213900-25-059248
Chunk: 2

Company: NewcelX Ltd.
Filing Date: 2025-06-30
Form: 6-K
Chunk 2
---
6        |     | Press release titled: “NLS Pharmaceutics and Kadimastem Announce Pricing and Closing of $1 Million Equity Financing.”                                                                                              |

<div align='center'>2

SIGNATURES</div>

Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

| Date: June 30, 2025 | NLS Pharmaceutics Ltd. 
 By:                    | /s/ Alexander Zwyer |                         |
|:--------------------|:-----------------------|:--------------------|:------------------------|
|                     |                        | Name:               | Alexander Zwyer         |
|                     |                        | Title:              | Chief Executive Officer |

<div align='center'>3</div>